vimarsana.com

Page 10 - நிதி நெருக்கமான News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Accolade raises one of the biggest VC, growth fund of funds backing women-led and diverse managers

The firm said it hopes the Empowerment Fund will be a catalyst to change that equation. Accolade managing partner Joelle Kayden said, “The Accolade team is passionate about investing in thought leaders who are launching funds to back a diverse set of founders and invest in technologies that can change the world and also drive strong returns. “Building more inclusive businesses is a priority for executives and a necessity to attract talent. “We believe Accolade’s managers will have a compelling advantage in winning competitive deals.” Accolade has raised $2.9bn of capital across a string of VC and growth fund of fund vehicles since it was founded in 2000.

Oil Search seeks beneficial outcome with PPL for Papua New Guinea PPA

Wave of LP biotech interest helps Ysios Capital to biggest-ever fund close

The firm outdid even that total thanks to backing from investors including the European Investment Fund, which doubled its initial €30m commitment to become the fund’s largest backer at 27.7%. Ysios is tapping Fund III to invest in companies developing disruptive therapeutic products and platform technologies, backing seed, early stage and development-stage businesses “at the forefront of the future of medicine”. About 80% of the YBF 3 investments will target Europe, with a special focus on Spain, while the remainder of the fund will target opportunities in North America. More than 60% of the portfolio has already been constructed, Ysios said, with eight investments made in the last 12 months by blue-chip European and US investors.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.